Aids Programme News Today

The renowned virologist from the University of Zurich receives the major award from the Bill & Melinda Gates Foundation for an innovative project on H....

Health Cabinet Secretary Nakhumicha said the decision puts Kenya on the driver's seat.

Researchers have been trying to develop antiretroviral medicines that can last weeks, months or even years per dose. Two such long-acting formulations have been approved in South Africa, but several more are on the horizon. Elri Voigt explores the science behind what makes a formulation long-ac...

Leading scientist, HIV/Aids expert and longstanding activist died on Wednesday at age 83.

TBWA\South Africa - The Disruption Company - is calling on young South African students to apply for the companys 2024 internship intake...

In what is likely to be one of the largest treatment roll-outs in South African history, well more than four million people living with HIV have started taking the antiretroviral dolutegravir since its introduction about four years ago. Now, according to a recent study published in the Lancet m...

Millions of doses of the Pfizer-BioNtech Covid-19 vaccine procured by the South African government have expired and the shot is largely unavailable to people in the country. Meanwhile, this month the World Health Organization declared an end to the Covid-19 ‘Public Health Emergency of Internati...

SA scientists have come up with a long Covid “dashboard” for the global community, so all the pieces of this complex disease puzzle they call “the second pandemic” can be put together.

Elri Voigt looks at the results from three studies on doxycycline as post-exposure prophylaxis (PEP) for STI prevention.

Johnson and Johnson becomes the latest pharmaceutical firm to withdraw a possible contender